📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. (2011)

First Author: Royston P

Attributed to: MRC Clinical Trials Unit as the London Hub for Trials Methodology Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/sim.4274

PubMed Identifier: 21611958

Publication URI: http://europepmc.org/abstract/MED/21611958

Type: Journal Article/Review

Volume: 30

Parent Publication: Statistics in medicine

Issue: 19

ISSN: 0277-6715